---
schema_version: "secwatch.filing_event.v1"
accession: "0000926326-24-000030"
form_type: "8-K"
ticker: "OMCL"
cik: "0000926326"
company_name: "OMNICELL, INC."
filed_at: "2024-10-30T23:59:59+00:00"
generated_at: "2026-05-30T08:48:50.866942+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Omnicell Q3 revenue $282M (-5% YoY); raises FY2024 non-GAAP EBITDA & EPS guidance

## Summary
- Q3 GAAP net income $9M ($0.19/diluted) vs. $6M ($0.12) YoY; non-GAAP EPS $0.56 vs. $0.62.
- Total revenues $282M, down 5% YoY due to health system headwinds and XT Series cycle timing.
- FY2024 guidance raised: non-GAAP EBITDA $129-134M, non-GAAP EPS $1.65-1.72.
- Appointed Nnamdi Njoku as EVP & COO; cash $571M, $350M revolver undrawn.
- Q4 2024 revenue guidance $295-305M; non-GAAP Q4 EPS $0.55-0.62.

## SEC filing metadata
- accession: 0000926326-24-000030
- form_type: 8-K
- ticker: OMCL
- cik: 0000926326
- company_name: OMNICELL, INC.
- filed_at: 2024-10-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926326/000092632624000030/0000926326-24-000030-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926326/000092632624000030/omcl-20241030.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000926326-24-000030
- JSON: https://secwatch.observer/filing/0000926326-24-000030.json
- Plain text: https://secwatch.observer/filing/0000926326-24-000030.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.